Literature DB >> 2212171

Treatment of vaginal candidiasis: orally or vaginally?

J M Merkus1.   

Abstract

Vaginal candidiasis continues to be the most common cause of vaginal discharge. A large variety of topical drugs and a selection of orally active antifungals are currently available. The choice between the use of oral drugs or intravaginal agents will depend on the therapeutic results obtained with the different agents, side effects, pregnancy status, and patient preference. The results obtained in the Maria Hospital, Tilburg, The Netherlands, and a review of foreign data suggest the following: (1) For acute infection oral and topical agents produce equivalent results. (2) For chronic infections oral medication is preferred. (3) Oral therapy should not be given to pregnant patients or to patients not using reliable contraceptive measures. (4) Half the patients prefer oral medication; only 5% prefer intravaginal therapy, and the others had no clear preference.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212171     DOI: 10.1016/0190-9622(90)70257-i

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Short-course itraconazole in the treatment of candida vulvovaginitis: A multicentre Canadian study.

Authors:  T W Austin; M Steben; M Powell; B Romanowski; D W Megran; G E Garber; L J Margesson
Journal:  Can J Infect Dis       Date:  1996-03

Review 2.  Local treatment of vulvovaginal candidosis : general and practical considerations.

Authors:  José das Neves; Eugénia Pinto; Branca Teixeira; Gustavo Dias; Patrocínia Rocha; Teresa Cunha; Bárbara Santos; Maria H Amaral; Maria F Bahia
Journal:  Drugs       Date:  2008       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.